Cenedella.de

Patient Advocate since 1977.

Study: Oral THC Safe And Effective For Treatment Of Spasticity In Pediatric Patients – Dusseldorf, Germany

Leave a comment

http://norml.org/news/2016/09/01/study-oral-thc-safe-and-effective-for-treatment-of-spasticity-in-pediatric-patients 

Thursday, 01 September 2016

Study: Oral THC Safe And Effective For Treatment Of Spasticity In Pediatric PatientsDusseldorf, Germany: The administration of oral, synthetic THC (dronabinol) is safe and effective for the treatment of refractory spasticity in pediatric patients, according to clinical data published online ahead of print in the European Journal of Pediatric Neurology.

Researchers from the University of Dusseldorf in Germany assessed the palliative treatment of dronabinol in 16 adolescent subjects with complex neurological conditions. Subjects received dosing twice daily and the median duration of treatment was 181 days.

Oral THC administration was associated with reduced spasticity in the majority of subjects treated. No serious or enduring side effects were reported. “Our data show evidence that dronabinol can effectively be administered over a longer period of time to … young children … without severe side effects or aggravation of pre-existing concurrent conditions,” authors concluded.

The study is one of the first trials to specifically assess the safety and efficacy of THC in an adolescent patient population.

The US Food and Drug Administration approved the prescription use of oral, synthetic THC as an anti-emetic and as an appetite stimulant in the mid 1980s. A liquid version of dronabinol was FDA approvedfor similar purposes earlier this year.

For more information, please contact Paul Armentano, NORML Deputy Director, at: paul@norml.org. Full text of the study, “Effective treatment of spasticity using dronabinol in pediatric palliative care,” appears in the European Journal of Pediatric Neurology.

Advertisements

Author: Cenedella.de

Philip J. Cenedella IV - The 2-continent Cannabis Consultant. First and foremost, I am a Patient Advocate since 1977. I have also served as a Board of Director for the World Trade Center San Diego, as a Lead Consultant for Deutsche Telekom's Executive Board, Founded the Dayton Human Trafficking Accords and have been a C-Level Business Development Executive for over 3 decades. From California, now residing in Germany and providing professional business development services to firms from North America, Europe and worldwide. I support the work of United States Congressman Dana Rohrabacher (pictured below at ICBC Berlin) and the BERLIN PEACE ACCORDS which call for an end to the world war on Cannabis. https://cenedella.de/berlin-peace-accords Consulting Services: Sales and Business Development - all facets, C-level, ethical and professional Assist with Strategic Direction - but focused on its implementation Professionally represent your firm - at conventions, sales meetings, and events Research - licensing, compliance, distribution networks and qualify potential partners I am your resource, on the ground in Europe! Philip J. Cenedella IV Call +1.888.206.3264 USA / +49.0.151.720.16752 GERMANY Skype: philip.j.cenedella / eMail: phil@cenedella.de

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s